- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05462782
TMS for Investigating Memory Facilitation
Task Paired Transcranial Magnetic Stimulation for Working Memory Potentiation
Study Overview
Status
Conditions
Detailed Description
The fundamental objective is to evaluate the changes derived from the specific Paired Associative Stimulation (PAS) protocol applying Transcranial Magnetic Stimulation (TMS) towards the hippocampus to enhance memory in an older population. We will evaluate the following effects: 1) Changes in memory capacity using task performance of the working memory (WM) task and calculating the correctly memorized items; and 2) Changes in brain connectivity using resting state functional Magnetic Resonance Imaging (rs-fMRI) and comparing the correlated activity between areas related to the process of memorization.
In order to understand the memory and brain connectivity changes derived from the PAS intervention more specifically, we will characterize the stimulation localization, the Inter Stimulus Interval (ISI) timing and rule out training and placebo effects. To research if the PAS effects are specific to the stimulated brain area, we will conduct a control group in which stimulation will be delivered to the primary motor area (M1). Then, we will compare the outcome measures (changes in memory capacity and brain connectivity) between the different brain areas. To characterize the ISI, our goal is to calculate the synchronization timing that triggers cortical plastic changes. Thus, we will test two different ISI between the TMS pulse delivery and memorization task. Finally, to differentiate the effects that are derived from the PAS versus the effects from repetition of the task or placebo effects, we will conduct another control group with Sham TMS stimulation and reproduce the same experimental procedures as the group that receives the TMS stimulation. Sham TMS is used in this study to compare if brain stimulation (active TMS) can help improve memory compared to receiving no brain stimulation (sham TMS).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Shirley Ryan AbilityLab
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria for Older Healthy Participants:
- Age from 60 to 85 years, inclusive (For piloting purposes, this inclusion criteria may vary).
- No history of a brain and/or skull lesion (e.g., stroke)
- Normal vision (can be corrected)
- Able to understand and give informed consent
- No neurological disorders
- Able to understand and speak English
Exclusion Criteria for Healthy Participants:
- Cardiac pacemaker or pacemaker wires; neurostimulators; implanted pumps
- Metal in the body (rods, plates, screws, shrapnel, dentures, IUD) or metallic particles in the eye
- Surgical clips in the head or previous neurosurgery
- Any magnetic particles in the body
- Cochlear implants
- Prosthetic heart valves
- Epilepsy or any other type of seizure history
- History of significant head trauma (i.e., extended loss of consciousness, neurological sequelae)
- Significant claustrophobia
- Ménière's disease
- Pregnancy or breast feeding
- Non prescribed drug use
- History of current substance abuse (exception: current nicotine use is allowed)
- Marijuana
- Any neurological diagnoses
- Dementia; severe depression; or prior neurosurgical procedures
- Tremor or parkinsonism, or psychiatric disease that would interfere with study procedures for TMS, or MRI.
- Significant other disease (cardiological or heart disease, renal, hepatic, malignant tumors, mental or psychiatric disorders) that would prevent participants from fully engaging in study procedures
- Prisoners
- Medications contraindicated for TMS: antipsychotic and antidepressant medications.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Active TMS
Older healthy participants will be scanned with MRI and undergo memory task synchronized PAS with an active TMS in each visit with different stimulation localization and ISIs.
|
The cone coil Cool-DB80 (MagPro, MagVenture, Alpharetta GA, US) will be used with an MRI-based TMS navigation system (Localite, St Augustin, Germany).
TMS interventions will involve the following parameters: 1. Hippocampal directed stimulation at ISI 0ms, 2. Hippocampal directed stimulation at ISI 200ms, 3. Motor cortex stimulation at ISI 0ms, and 4. Motor cortex stimulation at ISI 200ms.
|
|
Sham Comparator: Sham TMS
Older healthy participants will be scanned with MRI and undergo memory task synchronized PAS with a sham TMS coil in each visit with different ISIs application.
|
The sham coil Cool B65 A/P (MagPro, MagVenture, Alpharetta GA, US) will be used with an MRI-based TMS navigation system (Localite, St Augustin, Germany).
The different TMS interventions will be involve the following parameters: 1. Sham stimulation at ISI 0ms, and 2. Sham stimulation at ISI 200ms.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Working Memory (WM) capacity
Time Frame: Compared during each visit between baseline, immediately after the intervention, and 30 minutes after intervention
|
The WM task utilized is a customized version of the masking task model, presented by Sana Inoue and Tetsuro Matsuzawa, in 2007.
This task is organized in three phases: 1) Waiting phase: a visual cue is presented to indicate the initiation of the trial; 2) Coding and retention phase: numbers are presented in a random arrangement within a 5x5 square matrix; and 3) Recall phase: the numbers disappear, leaving a white background as a clue, and the subject completes the task by pressing the squares in the matrix following the incremental order of the numbers.
(Figure 2).
The task ends either when the subject makes a mistake or completes correctly selecting all numbers in incremental order.
The outcome measure for WM capacity is the amount of correctly remembered items (hit items) of each trial.
|
Compared during each visit between baseline, immediately after the intervention, and 30 minutes after intervention
|
|
Changes in resting state functional MRI connectivity
Time Frame: Compared during each visit between baseline and 30 minutes after intervention
|
The neural connectivity index that we will assess responds to the strength of synaptic connections between neurons and over time.
The identification of correlations between remote brain areas will be tested by resting state functional magnetic resonance imaging (rs-fMRI).
We will compare the connectivity network after intervention time with baseline and sham group.
Correlations of spontaneous modulations in the blood oxygen level dependent (BOLD) signal will be analyzed and regions with similar functional properties under resting conditions will be detected.
This analysis is able to identify significant long-lasting effects of active stimulation (vs.
sham) on brain connectivity.
|
Compared during each visit between baseline and 30 minutes after intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jose L Pons, Ph.D, Shirley Ryan AbilityLab
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- STU00216935
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Age-associated Memory Impairment
-
MicrophytTexas A&M UniversityCompletedAge-associated Memory ImpairmentUnited States
-
University of RochesterNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedAlteration of Cognitive Function | Age-associated Memory ImpairmentUnited States
-
CerecinCompleted
-
EnzymotecCompletedAge Associated Memory ImpairmentIsrael
-
Dart NeuroScience, LLCCompletedAge-Associated Memory Impairment (AAMI)United States
-
University of Novi Sad, Faculty of Sport and Physical...CompletedAge-associated Memory ImpairmentSerbia
-
Universidad Europea de MadridRecruitingMild Cognitive Impairment | Age-associated Memory ImpairmentSpain
-
University of California, San DiegoRecruitingCognitive Change | Aging | Mild Cognitive Impairment | Cognitive Decline | Memory Disorders | Memory Impairment | Cognition Disorders in Old Age | Aging Problems | Memory Loss | Memory Disorders in Old Age | Memory Disorder, SpatialUnited States
-
University of Dublin, Trinity CollegeAlzheimer's AssociationCompletedMild Cognitive Impairment | Memory Impairment | Memory Disorders in Old AgeIreland
-
University of California, Los AngelesCompletedMild Cognitive Impairment (MCI) | Age-associated Cognitive ImpairmentUnited States
Clinical Trials on Transcranial Magnetic Stimulation (TMS) Cone Coil
-
BrainswayCompletedAlzheimer's DiseaseIsrael
-
University Hospital Inselspital, BerneUniversity of Bern; Luzerner KantonsspitalCompletedHemispatial NeglectSwitzerland
-
El Instituto Nacional de Neurologia y Neurocirugia...CompletedPsychogenic Non-Epileptic SeizureMexico
-
Pamukkale UniversityCompletedOpioid Use DisorderTurkey
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH); Global Foundation for Eating Disorders and other collaboratorsRecruiting
-
Universidad Nacional Autonoma de MexicoUnknownMajor DepressionMexico
-
Anhui Medical UniversityRecruitingTranscranial Magnetic Stimulation | Obsessive-Compulsive Disorder | Functional Magnetic Resonance Imaging | Accelerated Continue Theta-burst StimulationChina
-
Amsterdam UMC, location VUmcZonMw: The Netherlands Organisation for Health Research and Development; Post...RecruitingLong COVID | Post COVID-19 Condition (PCC) | PASC Post Acute Sequelae of COVID 19Netherlands
-
Anhui Medical UniversityCompletedTranscranial Magnetic Stimulation | Obsessive-Compulsive Disorder | Functional Magnetic Resonance Imaging | Event-Related PotentialsChina
-
Emory UniversityNational Institute of Mental Health (NIMH)Completed